• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负向决定因素作为 CK2 靶向调节剂的重要性。 Akt2 S131 的教训。

The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131.

机构信息

Department of Biomedical Sciences, University of Padova, Padova, Italy.

Department of Molecular Medicine, University of Padova, Padova, Italy.

出版信息

PLoS One. 2018 Mar 1;13(3):e0193479. doi: 10.1371/journal.pone.0193479. eCollection 2018.

DOI:10.1371/journal.pone.0193479
PMID:29494643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5832243/
Abstract

CK2 is a pleiotropic S/T protein kinase (formerly known as casein kinase 2) which is attracting increasing interest as therapeutic target, and the identification of its substrates is a crucial step in determining its involvement in different pathological conditions. We recently found that S131 of Akt2 (homologous to the well established CK2 target S129 of Akt1) is not phosphorylated by CK2 either in vitro or in vivo, although the consensus sequence recognized by CK2 (S/T-x-x-E/D/pS/pT) is conserved in it. Here, by exploiting synthetic peptides, in cell transfection experiments, and computational analysis, we show that a single sequence element, a T at position n+1, hampers phosphorylation, causing an α-helix structure organization which prevents the recognition of its own consensus by CK2. Our results highlight the role of negative determinants as crucial modulators of CK2 targeting and corroborate the concept that Akt1 and Akt2 display isoform specific features. Experiments with synthetic peptides suggest that Akt2 S131 could be phosphorylated by kinases of the Plk (Polo-like kinase) family, which are insensitive to the presence of the n+1 T. The low phylogenetic conservation of the Akt2 sequence around S131, as opposed to the extremely well-conserved Akt1 homologous sequence, would indicate a dominant positive role in the selective pressure only for the Akt1 phosphoacceptor site committed to undergo phosphorylation by CK2. By contrast, Akt2 S131 may mediate the response to specific physio/pathological conditions, being consequently shielded against basal CK2 targeting.

摘要

CK2 是一种多功能 S/T 蛋白激酶(以前称为酪蛋白激酶 2),作为治疗靶点越来越受到关注,鉴定其底物是确定其在不同病理条件下参与的关键步骤。我们最近发现,Akt2 的 S131(与 Akt1 的成熟 CK2 靶标 S129 同源)既不在体内也不在体外被 CK2 磷酸化,尽管 CK2 识别的保守序列(S/T-x-x-E/D/pS/pT)在其中保守。在这里,我们通过利用合成肽、细胞转染实验和计算分析,表明一个单一的序列元素,即位置 n+1 的 T,会阻碍磷酸化,导致其自身的保守序列无法被 CK2 识别的α-螺旋结构组织。我们的结果强调了负决定因素作为 CK2 靶向的关键调节剂的作用,并证实了 Akt1 和 Akt2 显示同工型特异性特征的概念。合成肽实验表明,Akt2 的 S131 可以被 Plk(Polo 样激酶)家族的激酶磷酸化,而这些激酶对 n+1 T 的存在不敏感。与 Akt1 同源序列极其保守相比,Akt2 序列在 S131 周围的进化保守性较低,这表明在 CK2 磷酸化的选择性压力下,Akt1 的磷酸接受位点具有主导的积极作用。相比之下,Akt2 的 S131 可能介导对特定生理/病理条件的反应,因此免受基础 CK2 靶向的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/eb4381f0c221/pone.0193479.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/fcc77ef7e6ca/pone.0193479.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/1952c624b294/pone.0193479.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/0515415afe78/pone.0193479.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/2a02e2fd05f0/pone.0193479.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/eb4381f0c221/pone.0193479.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/fcc77ef7e6ca/pone.0193479.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/1952c624b294/pone.0193479.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/0515415afe78/pone.0193479.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/2a02e2fd05f0/pone.0193479.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf8/5832243/eb4381f0c221/pone.0193479.g005.jpg

相似文献

1
The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131.负向决定因素作为 CK2 靶向调节剂的重要性。 Akt2 S131 的教训。
PLoS One. 2018 Mar 1;13(3):e0193479. doi: 10.1371/journal.pone.0193479. eCollection 2018.
2
Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions.蛋白激酶CK2对Akt1和Akt2的差异性磷酸化可能解释了亚型特异性功能。
Biochim Biophys Acta. 2014 Sep;1843(9):1865-74. doi: 10.1016/j.bbamcr.2014.04.020. Epub 2014 Apr 24.
3
The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide.蛋白激酶CK2的调节性β亚基有助于识别底物共有序列。一项关于源自真核起始因子2β的肽段的研究。
Biochemistry. 2008 Aug 12;47(32):8317-25. doi: 10.1021/bi800216d. Epub 2008 Jul 18.
4
Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.CK2磷酸化后,RNA聚合酶II C末端结构域磷酸酶FCP1与RAP74的结合增强。
Biochemistry. 2005 Mar 1;44(8):2732-45. doi: 10.1021/bi047958h.
5
Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.丙型肝炎病毒NS2蛋白被蛋白激酶CK2磷酸化,并靶向降解至蛋白酶体。
J Virol. 2005 Mar;79(5):2700-8. doi: 10.1128/JVI.79.5.2700-2708.2005.
6
Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.只有Akt1参与细胞增殖,而Akt2通过与p21结合促进细胞周期退出。
Mol Cell Biol. 2006 Nov;26(22):8267-80. doi: 10.1128/MCB.00201-06. Epub 2006 Sep 18.
7
Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules.协调 AKT1 和 AKT2 分子上多个残基的磷酸化。
Oncogene. 2014 Jun 26;33(26):3463-72. doi: 10.1038/onc.2013.301. Epub 2013 Aug 5.
8
Protein kinase CK2 phosphorylates and upregulates Akt/PKB.蛋白激酶CK2使Akt/PKB磷酸化并上调其表达。
Cell Death Differ. 2005 Jun;12(6):668-77. doi: 10.1038/sj.cdd.4401604.
9
Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.对蛋白质激酶CK2抑制剂醌茜素在HEK-293T细胞中容易改变的磷酸化蛋白质组进行定量分析。
Biochim Biophys Acta. 2015 Jun;1854(6):609-23. doi: 10.1016/j.bbapap.2014.09.017. Epub 2014 Sep 30.
10
A historical view of protein kinase CK2.蛋白激酶CK2的历史视角。
Cell Mol Biol Res. 1994;40(5-6):383-90.

引用本文的文献

1
Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.下调 CK2β 亚基对 HK-2 肾细胞中 Akt 信号通路的影响。
PLoS One. 2020 Jan 7;15(1):e0227340. doi: 10.1371/journal.pone.0227340. eCollection 2020.

本文引用的文献

1
Protein kinase B: emerging mechanisms of isoform-specific regulation of cellular signaling in cancer.蛋白激酶B:癌症中细胞信号传导异构体特异性调节的新机制
Anticancer Drugs. 2017 Jul;28(6):569-580. doi: 10.1097/CAD.0000000000000496.
2
Cross-talk between the CK2 and AKT signaling pathways in cancer.癌症中CK2与AKT信号通路之间的相互作用。
Adv Biol Regul. 2017 May;64:1-8. doi: 10.1016/j.jbior.2017.03.002. Epub 2017 Mar 28.
3
Generation and quantitative proteomics analysis of CK2α/α' cells.CK2α/α' 细胞的生成与定量蛋白质组学分析。
Sci Rep. 2017 Feb 17;7:42409. doi: 10.1038/srep42409.
4
CK2-An Emerging Target for Neurological and Psychiatric Disorders.CK2——神经和精神疾病的新兴靶点。
Pharmaceuticals (Basel). 2017 Jan 5;10(1):7. doi: 10.3390/ph10010007.
5
Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain.蛋白激酶CK2通过UIM2结构域的磷酸化来调节HSJ1的功能。
Hum Mol Genet. 2017 Feb 1;26(3):611-623. doi: 10.1093/hmg/ddw420.
6
SPIDER2: A Package to Predict Secondary Structure, Accessible Surface Area, and Main-Chain Torsional Angles by Deep Neural Networks.SPIDER2:一个通过深度神经网络预测二级结构、可及表面积和主链扭转角的软件包。
Methods Mol Biol. 2017;1484:55-63. doi: 10.1007/978-1-4939-6406-2_6.
7
ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale.ACEMD:在微秒时间尺度上加速生物分子动力学
J Chem Theory Comput. 2009 Jun 9;5(6):1632-9. doi: 10.1021/ct9000685. Epub 2009 May 21.
8
CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.在体外和体内,CK2作为受体介导的胰岛素释放的有效负调节因子发挥作用。
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):E6818-24. doi: 10.1073/pnas.1519430112. Epub 2015 Nov 23.
9
The protein kinase 2 inhibitor tetrabromobenzotriazole protects against renal ischemia reperfusion injury.蛋白激酶2抑制剂四溴苯并三唑可预防肾缺血再灌注损伤。
Sci Rep. 2015 Oct 1;5:14816. doi: 10.1038/srep14816.
10
Signalling specificity in the Akt pathway in breast cancer.乳腺癌中Akt信号通路的信号特异性。
Biochem Soc Trans. 2014 Oct;42(5):1349-55. doi: 10.1042/BST20140160.